SCHEMBL24668909

SCHEMBL24668909

C=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 9/20 0.80
PDE3A Q14432 9/20 0.80
ALDH1A1 P00352 7/20 0.80
TSHR P16473 5/20 0.80
SMN1; SMN2 Q16637 4/20 0.80
LMNA P02545 3/20 0.80
MEN1 O00255 2/20 0.80
KMT2A Q03164 2/20 0.80
ABCC4 O15439 1/20 0.80
CACNA1F O60840 1/20 0.80
ABCB11 O95342 1/20 0.80
CYP1A2 P05177 1/20 0.80
CYP3A4 P08684 1/20 0.80
ADORA3 P0DMS8 1/20 0.80
CYP2C9 P11712 1/20 0.80
MAPK1 P28482 1/20 0.80
THPO P40225 1/20 0.80
OPRK1 P41145 1/20 0.80
BLM P54132 1/20 0.80
PMP22 Q01453 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12117982 0.93 PDE3B (0.69) PDE3BPDE3AALDH1A1TSHRSMN1; SMN2
Cilostazol SCHEMBL16128 0.89 PDE3B (1.00) PDE3BPDE3AALDH1A1TSHRSMN1; SMN2
Cilostazol SCHEMBL29389547 0.89 PDE3B (1.00) PDE3BPDE3AALDH1A1TSHRSMN1; SMN2
Cilostazol SCHEMBL1818013 0.89 PDE3B (1.00) PDE3BPDE3AALDH1A1TSHRSMN1; SMN2
SCHEMBL7307973 0.86 PDE3B (0.94) PDE3BPDE3AALDH1A1TSHRSMN1; SMN2
Cilostazol SCHEMBL5798390 0.86 PDE3B (0.93) PDE3BPDE3AALDH1A1TSHRSMN1; SMN2
Cilostazol SCHEMBL5798394 0.85 PDE3B (0.92) PDE3BPDE3AALDH1A1TSHRSMN1; SMN2
SCHEMBL25984910 0.83 PDE3B (0.71) PDE3BPDE3AALDH1A1TSHRSMN1; SMN2
SCHEMBL13128735 0.81 PDE3B (0.64) PDE3BPDE3AALDH1A1TSHRSMN1; SMN2
SCHEMBL12116425 0.81 PDE3B (0.86) PDE3BPDE3AALDH1A1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022161376-A1 USE OF COMPOSITION CONTAINING VINPOCETINE IN CEREBROVASCULAR DISEASES 南京宁丹新药技术有限公司 2022-08-04 WO disclosed